|View printer-friendly version|
|BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs|
"We are pleased to have
"I have been impressed by the progress BrainStorm has made with NurOwn, particularly the outstanding Phase 2 clinical data which showed meaningful improvements in disease symptoms," said
About BrainStorm Cell
Radicava™ is a registered trademark of Mitsubishi Tanabe Pharma America.
View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-supports-commitment-to-als-patient-community-with-appointment-of-a-vice-president-of-patient-advocacy-and-government-affairs-300499934.html